{"disease":{"id":"advanced-non-small-cell-lung-cancer-and-met-exon-14-skipping-mutation","name":"advanced non small cell lung cancer and met exon 14 skipping mutation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06161051","title":"Treatment Patterns and Real-World Clinical Outcomes in Patients With Advanced NSCLC and MET Exon 14 Skipping Mutation in the United States","phase":"","overall_status":"COMPLETED","enrollment_count":287,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}